Follow-The-Filings

Security · featured owners

TXG 10X Genomics Inc

10X Genomics Inc. COMMON STOCK Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 2.5%
  • $432M
  • 2 new 1 reduce

Who owns this now

Largest portfolio weights among featured holders · max 2.5% (Cathie Wood - Ark Investm...) · not free-float ownership

  1. Cathie Wood reduce 2.5%
  2. Ben Jacobs new 1.3%
  3. Stanley Druckenmiller new 0.30%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Cathie Wood - Ark Investment Management 2026 Q2 2.5% Reduce −14.6% 10,003,057 $384M history
Ben Jacobs - Anomaly Capital Management 2026 Q2 1.3% New 1.3% 867,794 $33M history
Stanley Druckenmiller - Duquesne Family Office 2026 Q2 0.30% New 0.30% 403,100 $15M history

3 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $618.73M $610.78M $642.82M
Gross profit $409.31M $414.48M $443.88M
Gross margin * 66.2% 67.9% 69.1%
Net income -$255.1M -$182.63M -$43.54M
Net margin * -41.2% -29.9% -6.8%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $596.02M $584.39M $684.45M
Total non-current assets * $369.12M $334.25M $356.91M
Total assets $965.14M $918.64M $1.04B
Total current liabilities $127.16M $117.63M $153.45M
Total non-current liabilities * $96.94M $90.87M $91.58M
Total equity $741.04M $710.13M $796.33M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$15.2M $6.66M $136.05M
Cash from investing $133.49M -$32.63M -$13.44M
Cash from financing $13.67M $10.91M $6.8M
Net change in cash $131.93M -$15.22M $129.9M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders